Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint von Hellmann, Matthew D, MD, Chaft, Jamie E, MD, William, William N, MD, Rusch, Valerie, Prof, Pisters, Katherine M W, Prof, Kalhor, Neda, MD, Pataer, Apar, MD, Travis, William D, Prof, Swisher, Stephen G, Prof, Kris, Mark G, Dr Prof

Volltext

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy von Pataer, Apar, Kalhor, Neda, Correa, Arlene M., Raso, Maria Gabriela, Erasmus, Jeremy J., Kim, Edward S., Behrens, Carmen, Lee, J. Jack, Roth, Jack A., Stewart, David J., Vaporciyan, Ara A., Wistuba, Ignacio I., Swisher, Stephen G.

Volltext

Abstract 2562: Affinity-enhanced T-cell receptor (TCR) for adoptive T-cell therapy targeting MAGE-A4 von Senra, Joana, Villalobos, Pamela, Mino, Barbara, Solis, Luisa, Behrens, Carmen, Sanderson, Joseph P., Saini, Manoj, Gerry, Andrew B., Pumphrey, Nicholas J., Maroto, Miguel, Sepesi, Boris, Hwu, Patrick, Hong, David S., Mittendorf, Elizabeht A., Blumenschein, George S., Wistuba, Ignacio I., Binder-Scholl, Gwendolyn, Amado, Rafael

Volltext

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer von Garon, Edward B, Rizvi, Naiyer A, Hui, Rina, Leighl, Natasha, Balmanoukian, Ani S, Eder, Joseph Paul, Patnaik, Amita, Aggarwal, Charu, Gubens, Matthew, Horn, Leora, Carcereny, Enric, Ahn, Myung-Ju, Felip, Enriqueta, Lee, Jong-Seok, Hellmann, Matthew D, Hamid, Omid, Goldman, Jonathan W, Soria, Jean-Charles, Dolled-Filhart, Marisa, Rutledge, Ruth Z, Zhang, Jin, Lunceford, Jared K, Rangwala, Reshma, Lubiniecki, Gregory M, Roach, Charlotte, Emancipator, Kenneth, Gandhi, Leena

Volltext

Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy von BLUMENSCHEIN, George R, MILLS, Gordon B, GONZALEZ-ANGULO, Ana M

Volltext

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck von Ferris, Robert L, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E, Even, Caroline, Worden, Francis, Saba, Nabil F, Iglesias Docampo, Lara C, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J, Kopit, Justin, Shaw, James W, Gillison, Maura L

Volltext

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer von Liao, Zhongxing, Lee, J Jack, Komaki, Ritsuko, Gomez, Daniel R, O'Reilly, Michael S, Fossella, Frank V, Blumenschein, Jr, George R, Heymach, John V, Vaporciyan, Ara A, Swisher, Stephen G, Allen, Pamela K, Choi, Noah Chan, DeLaney, Thomas F, Hahn, Stephen M, Cox, James D, Lu, Charles S, Mohan, Radhe

Volltext

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase I... von Gomez, Daniel R, Tang, Chad, Zhang, Jianjun, Blumenschein, Jr, George R, Hernandez, Mike, Lee, J Jack, Ye, Rong, Palma, David A, Louie, Alexander V, Camidge, D Ross, Doebele, Robert C, Skoulidis, Ferdinandos, Gaspar, Laurie E, Welsh, James W, Gibbons, Don L, Karam, Jose A, Kavanagh, Brian D, Tsao, Anne S, Sepesi, Boris, Swisher, Stephen G, Heymach, John V

Volltext

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC von Hong, Lingzhi, Negrao, Marcelo V., Dibaj, Seyedeh S., Chen, Runzhe, Reuben, Alexandre, Bohac, Jadi M., Liu, Xiaoke, Skoulidis, Ferdinandos, Gay, Carl M., Cascone, Tina, Mitchell, Kyle G., Tran, Hai T., Le, Xiuning, Byers, Lauren A., Sepesi, Boris, Altan, Mehmet, Elamin, Yasir Y., Fossella, Frank V., Kurie, Jonathan M., Lu, Charles, Mott, Frank E., Tsao, Anne S., Rinsurongkawong, Waree, Lewis, Jeff, Gibbons, Don L., Glisson, Bonnie S., Blumenschein, George R., Roarty, Emily B., Futreal, P. Andrew, Wistuba, Ignacio I., Roth, Jack A., Swisher, Stephen G., Papadimitrakopoulou, Vassiliki A., Heymach, John V., Lee, J. Jack, Simon, George R., Zhang, Jianjun

Volltext

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy von Munster, Pamela, Mita, Monica, Mahipal, Amit, Nemunaitis, John, Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Paz-Ares, Luis, Hidalgo, Manuel, Rathkopf, Dana, Blumenschein, Jr, George, Smith, David C, Eichhorst, Barbara, Cloughesy, Tim, Filvaroff, Ellen H, Li, Shaoyi, Raymon, Heather, de Haan, Hans, Hege, Kristen, Bendell, Johanna C

Volltext

Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation — Positive Advanced Non–Small C... von Spigel, David R., Reynolds, Craig, Waterhouse, David, Garon, Edward B., Chandler, Jason, Babu, Sunil, Thurmes, Paul, Spira, Alexander, Jotte, Robert, Zhu, Jin, Lin, Wen Hong, Blumenschein, George

Volltext

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck von Ferris, Robert L., Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Iglesias Docampo, Lara C., Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J., Kopit, Justin, Shaw, James W., Gillison, Maura L.

Volltext

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic the... von Gomez, Daniel R, Dr, Blumenschein, George R, Prof, Lee, J Jack, Prof, Hernandez, Mike, MS, Ye, Rong, MS, Camidge, D Ross, Prof, Doebele, Robert C, MD, Skoulidis, Ferdinandos, MD, Gaspar, Laurie E, Prof, Gibbons, Don L, MD, Karam, Jose A, MD, Kavanagh, Brian D, Prof, Tang, Chad, MD, Komaki, Ritsuko, Prof, Louie, Alexander V, MD, Palma, David A, MD, Tsao, Anne S, MD, Sepesi, Boris, MD, William, William N, MD, Zhang, Jianjun, MD, Shi, Qiuling, PhD, Wang, Xin Shelley, MD, Swisher, Stephen G, Prof, Heymach, John V, Prof

Volltext

PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell... von Negrao, Marcelo V., Lam, Vincent K., Reuben, Alexandre, Rubin, Maria Laura, Landry, Lara Lacerda, Roarty, Emily B., Rinsurongkawong, Waree, Lewis, Jeff, Roth, Jack A., Swisher, Stephen G., Gibbons, Don L., Wistuba, Ignacio I., Papadimitrakopoulou, Vassiliki, Glisson, Bonnie S., Blumenschein, George R., Lee, J. Jack, Heymach, John V., Zhang, Jianjun

Volltext

Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324 von BLUMENSCHEIN, George R, PAULUS, Rebecca, CURRAN, Walter J, ROBERT, Francisco, FOSSELLA, Frank, WERNER-WASIK, Maria, HERBST, Roy S, DOESCHER, Philip O, CHOY, Hak, KOMAKI, Ritsuko

Volltext

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A02+ patients: a phase 1 trial von Hong, David S., Van Tine, Brian A., Biswas, Swethajit, McAlpine, Cheryl, Johnson, Melissa L., Olszanski, Anthony J., Clarke, Jeffrey M., Araujo, Dejka, Blumenschein, George R., Kebriaei, Partow, Lin, Quan, Tipping, Alex J., Sanderson, Joseph P., Wang, Ruoxi, Trivedi, Trupti, Annareddy, Thejo, Bai, Jane, Rafail, Stavros, Sun, Amy, Fernandes, Lilliam, Navenot, Jean-Marc, Bushman, Frederic D., Everett, John K., Karadeniz, Derin, Broad, Robyn, Isabelle, Martin, Naidoo, Revashnee, Bath, Natalie, Betts, Gareth, Wolchinsky, Zohar, Batrakou, Dzmitry G., Van Winkle, Erin, Elefant, Erica, Ghobadi, Armin, Cashen, Amanda, Grand’Maison, Anne, McCarthy, Philip, Fracasso, Paula M., Norry, Elliot, Williams, Dennis, Druta, Mihaela, Liebner, David A., Odunsi, Kunle, Butler, Marcus O.

Volltext

Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study von Horn, Leora, Infante, Jeffrey R, Reckamp, Karen L, Blumenschein, George R, Leal, Ticiana A, Waqar, Saiama N, Gitlitz, Barbara J, Sanborn, Rachel E, Whisenant, Jennifer G, Du, Liping, Neal, Joel W, Gockerman, Jon P, Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J, Holzhausen, Allison, Lovly, Christine M, Wakelee, Heather A

Volltext

cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes von RAGHAV, Kanwal P, WENTING WANG, SHUYING LIU, CHAVEZ-MACGREGOR, Mariana, XIAOLONG MENG, HORTOBAGYI, Gabriel N, MILLS, Gordon B, MERIC-BERNSTAM, Funda, BLUMENSCHEIN, George R, GONZALEZ-ANGULO, Ana M

Volltext

Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized... von Haddad, Robert, Concha‐Benavente, Fernando, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Kasper, Stefan, Vokes, Everett E., Worden, Francis, Saba, Nabil F., Tahara, Makoto, Jayaprakash, Vijayvel, Lynch, Mark, Li, Li, Gillison, Maura L., Harrington, Kevin J., Ferris, Robert L.

Volltext

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kina... von HERBST, Roy S, JOHNSON, David H, HONG, Waun K, TRAN, Hai, TSAO, Anne, DONG XIE, RAMIES, David A, MASS, Robert, SESHAGIRI, Somasekar, EBERHARD, David A, KELLEY, Sean K, SANDLER, Alan, MININBERG, Eric, CARBONE, David P, HENDERSON, Ted, KIM, Edward S, BLUMENSCHEIN, George JR, LEE, Jack J, LIU, Diane D, TRUONG, Mylene T

Volltext